Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study

Identifieur interne : 001B88 ( PascalFrancis/Corpus ); précédent : 001B87; suivant : 001B89

Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study

Auteurs : Elan Louis ; Carol Moskowitz ; Michael Friez ; Maria Amaya ; Jean Paul G. Vonsattel

Source :

RBID : Pascal:06-0208456

Descripteurs français

English descriptors

Abstract

A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 21
A06       @2 3
A08 01  1  ENG  @1 Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study
A11 01  1    @1 LOUIS (Elan)
A11 02  1    @1 MOSKOWITZ (Carol)
A11 03  1    @1 FRIEZ (Michael)
A11 04  1    @1 AMAYA (Maria)
A11 05  1    @1 VONSATTEL (Jean Paul G.)
A14 01      @1 Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University @2 New York, New York @3 USA @Z 1 aut.
A14 02      @1 Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University @2 New York, New York @3 USA @Z 1 aut. @Z 2 aut.
A14 03      @1 Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University @2 New York, New York @3 USA @Z 1 aut. @Z 4 aut. @Z 5 aut.
A14 04      @1 Molecular Diagnostic Laboratory, Greenwood Genetic Center @2 Greenwood, South Carolina @3 USA @Z 3 aut.
A20       @1 420-425
A21       @1 2006
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000142800450240
A44       @0 0000 @1 © 2006 INIST-CNRS. All rights reserved.
A45       @0 7 ref.
A47 01  1    @0 06-0208456
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C02 03  X    @0 002B17H
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Parkinsonisme @2 NM @5 02
C03 02  X  ENG  @0 Parkinsonism @2 NM @5 02
C03 02  X  SPA  @0 Parkinson síndrome @2 NM @5 02
C03 03  X  FRE  @0 X fragile syndrome @5 03
C03 03  X  ENG  @0 Fragile X syndrome @5 03
C03 03  X  SPA  @0 X frágil síndrome @5 03
C03 04  X  FRE  @0 Tremblement @5 04
C03 04  X  ENG  @0 Tremor @5 04
C03 04  X  SPA  @0 Temblor @5 04
C03 05  X  FRE  @0 Ataxie @5 05
C03 05  X  ENG  @0 Ataxia @5 05
C03 05  X  SPA  @0 Ataxia @5 05
C03 06  X  FRE  @0 Inclusion @5 09
C03 06  X  ENG  @0 Inclusion @5 09
C03 06  X  SPA  @0 Inclusión @5 09
C03 07  X  FRE  @0 Porteur @5 10
C03 07  X  ENG  @0 Carrier @5 10
C03 07  X  SPA  @0 Portador @5 10
C03 08  X  FRE  @0 Anatomopathologie @5 11
C03 08  X  ENG  @0 Anatomic pathology @5 11
C03 08  X  SPA  @0 Anatomía patológica @5 11
C07 01  X  FRE  @0 Fragilité chromosomique @5 37
C07 01  X  ENG  @0 Chromosome fragility @5 37
C07 01  X  SPA  @0 Fragilidad cromosómica @5 37
C07 02  X  FRE  @0 Mouvement involontaire @5 38
C07 02  X  ENG  @0 Involuntary movement @5 38
C07 02  X  SPA  @0 Movimiento involuntario @5 38
C07 03  X  FRE  @0 Trouble neurologique @5 39
C07 03  X  ENG  @0 Neurological disorder @5 39
C07 03  X  SPA  @0 Trastorno neurológico @5 39
C07 04  X  FRE  @0 Encéphale pathologie @5 40
C07 04  X  ENG  @0 Cerebral disorder @5 40
C07 04  X  SPA  @0 Encéfalo patología @5 40
C07 05  X  FRE  @0 Système nerveux central pathologie @5 41
C07 05  X  ENG  @0 Central nervous system disease @5 41
C07 05  X  SPA  @0 Sistema nervosio central patología @5 41
N21       @1 135
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 06-0208456 INIST
ET : Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study
AU : LOUIS (Elan); MOSKOWITZ (Carol); FRIEZ (Michael); AMAYA (Maria); VONSATTEL (Jean Paul G.)
AF : Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University/New York, New York/Etats-Unis (1 aut.); Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University/New York, New York/Etats-Unis (1 aut., 2 aut.); Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University/New York, New York/Etats-Unis (1 aut., 4 aut., 5 aut.); Molecular Diagnostic Laboratory, Greenwood Genetic Center/Greenwood, South Carolina/Etats-Unis (3 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2006; Vol. 21; No. 3; Pp. 420-425; Bibl. 7 ref.
LA : Anglais
EA : A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.
CC : 002B17; 002B17G; 002B17H
FD : Système nerveux pathologie; Parkinsonisme; X fragile syndrome; Tremblement; Ataxie; Inclusion; Porteur; Anatomopathologie
FG : Fragilité chromosomique; Mouvement involontaire; Trouble neurologique; Encéphale pathologie; Système nerveux central pathologie
ED : Nervous system diseases; Parkinsonism; Fragile X syndrome; Tremor; Ataxia; Inclusion; Carrier; Anatomic pathology
EG : Chromosome fragility; Involuntary movement; Neurological disorder; Cerebral disorder; Central nervous system disease
SD : Sistema nervioso patología; Parkinson síndrome; X frágil síndrome; Temblor; Ataxia; Inclusión; Portador; Anatomía patológica
LO : INIST-20953.354000142800450240
ID : 06-0208456

Links to Exploration step

Pascal:06-0208456

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study</title>
<author>
<name sortKey="Louis, Elan" sort="Louis, Elan" uniqKey="Louis E" first="Elan" last="Louis">Elan Louis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Moskowitz, Carol" sort="Moskowitz, Carol" uniqKey="Moskowitz C" first="Carol" last="Moskowitz">Carol Moskowitz</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Friez, Michael" sort="Friez, Michael" uniqKey="Friez M" first="Michael" last="Friez">Michael Friez</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Molecular Diagnostic Laboratory, Greenwood Genetic Center</s1>
<s2>Greenwood, South Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Amaya, Maria" sort="Amaya, Maria" uniqKey="Amaya M" first="Maria" last="Amaya">Maria Amaya</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vonsattel, Jean Paul G" sort="Vonsattel, Jean Paul G" uniqKey="Vonsattel J" first="Jean Paul G." last="Vonsattel">Jean Paul G. Vonsattel</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0208456</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0208456 INIST</idno>
<idno type="RBID">Pascal:06-0208456</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B88</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study</title>
<author>
<name sortKey="Louis, Elan" sort="Louis, Elan" uniqKey="Louis E" first="Elan" last="Louis">Elan Louis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Moskowitz, Carol" sort="Moskowitz, Carol" uniqKey="Moskowitz C" first="Carol" last="Moskowitz">Carol Moskowitz</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Friez, Michael" sort="Friez, Michael" uniqKey="Friez M" first="Michael" last="Friez">Michael Friez</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Molecular Diagnostic Laboratory, Greenwood Genetic Center</s1>
<s2>Greenwood, South Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Amaya, Maria" sort="Amaya, Maria" uniqKey="Amaya M" first="Maria" last="Amaya">Maria Amaya</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vonsattel, Jean Paul G" sort="Vonsattel, Jean Paul G" uniqKey="Vonsattel J" first="Jean Paul G." last="Vonsattel">Jean Paul G. Vonsattel</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anatomic pathology</term>
<term>Ataxia</term>
<term>Carrier</term>
<term>Fragile X syndrome</term>
<term>Inclusion</term>
<term>Nervous system diseases</term>
<term>Parkinsonism</term>
<term>Tremor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Parkinsonisme</term>
<term>X fragile syndrome</term>
<term>Tremblement</term>
<term>Ataxie</term>
<term>Inclusion</term>
<term>Porteur</term>
<term>Anatomopathologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>21</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>LOUIS (Elan)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MOSKOWITZ (Carol)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>FRIEZ (Michael)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>AMAYA (Maria)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>VONSATTEL (Jean Paul G.)</s1>
</fA11>
<fA14 i1="01">
<s1>Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Molecular Diagnostic Laboratory, Greenwood Genetic Center</s1>
<s2>Greenwood, South Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>420-425</s1>
</fA20>
<fA21>
<s1>2006</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000142800450240</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>06-0208456</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>X fragile syndrome</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Fragile X syndrome</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>X frágil síndrome</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Tremblement</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Tremor</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Temblor</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Ataxie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Ataxia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Ataxia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Inclusion</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Inclusion</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Inclusión</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Porteur</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Carrier</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Portador</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Anatomopathologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Anatomic pathology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Anatomía patológica</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Fragilité chromosomique</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Chromosome fragility</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Fragilidad cromosómica</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>135</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 06-0208456 INIST</NO>
<ET>Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study</ET>
<AU>LOUIS (Elan); MOSKOWITZ (Carol); FRIEZ (Michael); AMAYA (Maria); VONSATTEL (Jean Paul G.)</AU>
<AF>Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University/New York, New York/Etats-Unis (1 aut.); Division of Movement Disorders, Department of Neurology, College of Physicians and Surgeons, Columbia University/New York, New York/Etats-Unis (1 aut., 2 aut.); Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons. Columbia University/New York, New York/Etats-Unis (1 aut., 4 aut., 5 aut.); Molecular Diagnostic Laboratory, Greenwood Genetic Center/Greenwood, South Carolina/Etats-Unis (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2006; Vol. 21; No. 3; Pp. 420-425; Bibl. 7 ref.</SO>
<LA>Anglais</LA>
<EA>A new tremor-ataxia syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), has been described among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation I (FMR1) gene. The prevalence of FMR1 premutation alleles has been reported to be 1 in 813 among men. Patients with FXTAS may also have features of parkinsonism. Postmortem findings have been described in eight patients with FXTAS and detailed descriptions of the pathological features of this syndrome have been published in two of these. We present a detailed description of the postmortem findings in a third patient. The patient had parkinsonism and was a carrier of a premutation expansion in the FMR1 gene. As in previous reports, the most prominent finding was the presence of eosinophilic nuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and regional vacuolation of the cerebral white matter. As in one previous report, nuclear inclusions were also present in ependymal and choroid plexus cells. A new finding is that of nuclear inclusions in both the adeno- and neurohypophysis. These findings confirm the diffuse nature of this pathology. Further studies of clinical-pathological correlation in a larger sample of brains would provide additional insight into the mechanisms of the tremor, ataxia, and parkinsonism in these patients.</EA>
<CC>002B17; 002B17G; 002B17H</CC>
<FD>Système nerveux pathologie; Parkinsonisme; X fragile syndrome; Tremblement; Ataxie; Inclusion; Porteur; Anatomopathologie</FD>
<FG>Fragilité chromosomique; Mouvement involontaire; Trouble neurologique; Encéphale pathologie; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Parkinsonism; Fragile X syndrome; Tremor; Ataxia; Inclusion; Carrier; Anatomic pathology</ED>
<EG>Chromosome fragility; Involuntary movement; Neurological disorder; Cerebral disorder; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson síndrome; X frágil síndrome; Temblor; Ataxia; Inclusión; Portador; Anatomía patológica</SD>
<LO>INIST-20953.354000142800450240</LO>
<ID>06-0208456</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B88 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001B88 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0208456
   |texte=   Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier : A clinical-pathological study
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024